The top 20 biopharmaceutical companies saw prominent shifts in market capitalisa...
US FDA placed a partial clinical hold on HIV programme and a full hold on Covid-...
BlossomHill has secured $100m in a Series B financing round to advance its progr...
1910 Genetics has entered an agreement with Microsoft, aiming to revitalise phar...
Flu vaccine appears to be offering reasonable levels of protection this winter, ...
In today's Pharmalittle roundup, we're reading about the White House eyeing PBMs...
Clinical research giant Icon has acquired HumanFirst, which has an extensive lib...
Jean Cui, a former Pfizer chemist, has raised $173 million from a coalition of t...
Kenai Therapeutics plans to move into a clinical trial within the year for its l...
Kristina Burow, managing director at ARCH Venture Partners and a member of the 2...
Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer ar...
Novo Nordisk's ideas about long-lasting molecules are a long way off from materi...
For developmental-stage biotechs, PIPEs have become an increasingly common metho...
Facing a growing outbreak of measles, the U.K. unveiled an advertising campaign ...
Amid concerns over Joe Biden's health and age, his physician says the president ...
